Acuta Capital Partners, LLC Portfolio Holdings

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Acuta Capital Partners, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $98.8 Million distributed in 41 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $15.5M, Ocular Therapeutix, Inc with a value of $10.4M, Insmed Inc with a value of $7.85M, Crinetics Pharmaceuticals, Inc. with a value of $6.73M, and Mereo Biopharma Group PLC with a value of $5.18M.

Examining the 13F form we can see an increase of $5.91M in the current position value, from $92.9M to 98.8M.

Acuta Capital Partners, LLC is based out at Belmont, CA

Below you can find more details about Acuta Capital Partners, LLC portfolio as well as his latest detailed transactions.

Portfolio value $98.8 Million
Healthcare: $98.8 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$32.7B
$3.2 Million 3.24% of portfolio
5,900
Q3 2024 Added 47.5%
$111B
$1.63 Million 1.65% of portfolio
19,500
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 41
  • Current Value $98.8 Million
  • Prior Value $92.9 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 16 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email